Primary Site >> Biliary tract Cancer

Gene >> CDAN1

Journal: Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):144-53.
Title: Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.
Author: Brunner, Thomas B|Grabenbauer, Gerhard G|Klein, Peter|Baum, Ulrich|Papadopoulos, Thomas|Bautz, Werner|Hohenberger, Werner|Sauer, Rolf
PMID: 12504047
Journal: Eur J Cancer. 2003 Sep;39(13):1842-51.
Title: Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours.
Author: Twelves, C|Hoekman, K|Bowman, A|Vermorken, J B|Anthoney, A|Smyth, J|van Kesteren, C|Beijnen, J H|Uiters, J|Wanders, J|Gomez, J|Guzman, C|Jimeno, J|Hanauske, A
PMID: 12932661
Journal: Cancer Chemother Pharmacol. 2007 Feb;59(3):285-93.
Title: Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
Author: Zhu, Andrew X|Clark, Jeffrey W|Ryan, David P|Meyerhardt, Jeffrey A|Enzinger, Peter C|Earle, Craig C|Fuchs, Charles S|Regan, Eileen|Anbe, Hiroshi|Houghton, Michele|Zhang, Joshua|Urrea, Peter|Kulke, Matthew H
PMID: 16786333
Journal: Cancer Chemother Pharmacol. 2008 Sep;62(4):727-33.
Title: A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
Author: Schelman, William|Morgan-Meadows, Sherry|Bailey, Howard|Holen, Kyle|Thomas, James P|Eickhoff, Jens|Brandon, Heidi|Oliver, Kate|Alberti, Dona|Wilding, George
PMID: 18172649
Journal: Cancer Chemother Pharmacol. 2014 Jun;73(6):1295-301.
Title: Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004).
Author: Toyoda, Masanori|Ajiki, Tetsuo|Fujiwara, Yutaka|Nagano, Hiroaki|Kobayashi, Shogo|Sakai, Daisuke|Hatano, Etsuro|Kanai, Masashi|Nakamori, Shoji|Miyamoto, Atsushi|Tsuji, Akihito|Kaihara, Satoshi|Ikoma, Hisashi|Takemura, Shigekazu|Toyokawa, Hideyoshi|Terajima
PMID: 24614947
Journal: Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1025-31.
Title: Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.
Author: Hickey, Ryan|Mulcahy, Mary F|Lewandowski, Robert J|Gates, Vanessa L|Vouche, Michael|Habib, Ali|Kircher, Sheetal|Newman, Steven|Nimeiri, Halla|Benson, Al B|Salem, Riad
PMID: 24661655
Journal: Cancer Chemother Pharmacol. 2015 Jan;75(1):191-6.
Title: Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.
Author: Uwagawa, Tadashi|Sakamoto, Taro|Abe, Kyohei|Okui, Norimitsu|Hata, Daigo|Shiba, Hiroaki|Futagawa, Yasuro|Aiba, Keisuke|Yanaga, Katsuhiko
PMID: 25422155
Journal: J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):669-74.
Title: Phase I study of gemcitabine, cisplatin, and S-1 combination therapy for patients with untreated advanced biliary tract cancer.
Author: Moriwaki, Toshikazu|Ishida, Hiroyasu|Araki, Masahiro|Endo, Shinji|Yoshida, Shigemasa|Kobayashi, Mariko|Hamano, Yukako|Sugaya, Akinori|Shimoyamada, Masahiro|Hasegawa, Naoyuki|Imanishi, Mamiko|Ito, Yuka|Sato, Daiki|Hyodo, Ichinosuke
PMID: 25877225
Journal: Invest New Drugs. 2018 Jul 11. pii: 10.1007/s10637-018-0634-5.
Title: Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer.
Author: Ikeda, Masafumi|Ohno, Izumi|Ueno, Hideki|Mitsunaga, Shuichi|Hashimoto, Yusuke|Okusaka, Takuji|Kondo, Shunsuke|Sasaki, Mitsuhito|Sakamoto, Yasunari|Takahashi, Hideaki|Hara, Rina|Kobayashi, Shingo|Nakamura, Osamu|Morizane, Chigusa
PMID: 29995287